Increases in cardiac kinins as a new mechanism to protect the heart.
- 1 April 1994
- journal article
- abstracts
- Published by Wolters Kluwer Health in Hypertension
- Vol. 23 (4) , 419-421
- https://doi.org/10.1161/01.hyp.23.4.419
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Angiotensin-converting enzyme inhibition improves cardiac function. Role of bradykinin.Hypertension, 1994
- Bradykinin peptides in kidney, blood, and other tissues of the rat.Hypertension, 1993
- Ramiprilat increases bradykinin outflow from isolated hearts of ratBritish Journal of Pharmacology, 1993
- Effect of early onset angiotensin converting enzyme inhibition on myocardial capillaries.Hypertension, 1992
- Salt intake and angiotensin II alter microvessel density in the cremaster muscle of normal ratsAmerican Journal of Physiology-Heart and Circulatory Physiology, 1992
- A specific B2‐bradykinin receptor antagonist HOE 140 abolishes the antihypertrophic effect of ramiprilBritish Journal of Pharmacology, 1992
- Differential regulation of angiotensin peptide levels in plasma and kidney of the rat.Hypertension, 1991
- Endothelium-derived bradykinin is responsible for the increase in calcium produced by angiotensin-converting enzyme inhibitors in human endothelial cellsNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1991
- Effects of the angiotensin converting enzyme inhibitor, ramipril, in isolated ischaemic rat heart are abolished by a bradykinin antagonistJournal Of Hypertension, 1988
- The Kallikreinogen-Kallikrein Enzyme System of Human PlasmaAnnals of Internal Medicine, 1969